KPIs & Operating Metrics(New)
Growth Metrics

Aurora Cannabis (ACB) Common Equity (2018 - 2025)

Aurora Cannabis has reported Common Equity over the past 8 years, most recently at $407.2 million for Q4 2025.

  • Quarterly Common Equity fell 7.12% to $407.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $407.2 million through Dec 2025, down 7.12% year-over-year, with the annual reading at $424.1 million for FY2025, 29.53% down from the prior year.
  • Common Equity was $407.2 million for Q4 2025 at Aurora Cannabis, down from $412.1 million in the prior quarter.
  • Over five years, Common Equity peaked at $1.7 billion in Q1 2021 and troughed at $362.9 million in Q1 2023.
  • The 5-year median for Common Equity is $432.8 million (2022), against an average of $688.1 million.
  • Year-over-year, Common Equity tumbled 71.73% in 2022 and then grew 16.47% in 2024.
  • A 5-year view of Common Equity shows it stood at $1.6 billion in 2021, then crashed by 71.73% to $438.3 million in 2022, then dropped by 6.46% to $410.0 million in 2023, then grew by 6.92% to $438.4 million in 2024, then dropped by 7.12% to $407.2 million in 2025.
  • Per Business Quant, the three most recent readings for ACB's Common Equity are $407.2 million (Q4 2025), $412.1 million (Q3 2025), and $424.9 million (Q2 2025).